Q32 Bio (QTTB) Change in Cash (2017 - 2026)
Q32 Bio (QTTB) posted quarterly Change in Cash of $2.5 million for Q1 2026, up 119.66% year-over-year from $1.1 million in Q1 2025, and up 430.73% quarter-over-quarter from -$742000.0 in Q4 2025.
Q32 Bio (QTTB) Change in Cash (2017 - 2026) Analysis & Trends
Q32 Bio's Change in Cash history runs 10 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Change in Cash rose 119.66% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at -$14.7 million (up 70.55% YoY), while the FY2025 annual figure was -$29.7 million, down 162.66% from the prior year.
- Change in Cash for Q1 2026 stood at $2.5 million, up from -$742000.0 in the prior quarter.
- The five-year high for Change in Cash was $138.1 million in Q1 2022, with the low at -$133.0 million in Q3 2022.
- The 5-year median for Change in Cash is -$10.6 million (2023), against an average of -$4.4 million.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 707.0% in 2022, then jumped 779.9% in 2024.
- Q32 Bio's Change in Cash stood at -$9.2 million in 2022, then slipped by 15.94% to -$10.6 million in 2023, then declined by 4.46% to -$11.1 million in 2024, then surged by 93.32% to -$742000.0 in 2025, then soared by 430.73% to $2.5 million in 2026.
- Business Quant data shows QTTB's Change in Cash at $2.5 million in Q1 2026, -$742000.0 in Q4 2025, and -$5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | 55.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.52 Mn |
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | -742,000.00 |
| Sep 30, 2025 | -5.79 Mn |
| Jun 30, 2025 | -10.65 Mn |
| Mar 31, 2025 | -12.48 Mn |
| Dec 31, 2024 | -11.11 Mn |
| Sep 30, 2024 | -8.58 Mn |
| Jun 30, 2024 | -17.85 Mn |
| Mar 31, 2024 | 84.89 Mn |
| Dec 31, 2023 | -10.64 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Mar 31, 2023 | -12.49 Mn |
| Dec 31, 2022 | -9.18 Mn |
| Sep 30, 2022 | -133.03 Mn |
| Jun 30, 2022 | -72.22 Mn |
| Mar 31, 2022 | 138.07 Mn |
| Dec 31, 2021 | 13.23 Mn |
| Sep 30, 2021 | -20.48 Mn |